Deepak Fertilis.
Deepak Fertilis. Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
1 of 3 strong
Not discussed on this call: fundraise, order book.
The short version
New capacities at Gopalpur (TAN) and Dahej (acids) coming on stream will contribute to revenue growth starting Q3/Q4 FY27 and will achieve near-optimum utilization by FY28. The company is entering the next phase of growth with new capacities (Gopalpur TAN and Dahej nitric acid projects) commissioning in Q2 FY27, expected to contribute from Q3/Q4 FY27 onwards.
From Deepak Fertilis.'s Q1 FY27 earnings-call transcript · updated 3 Sept 2026.
Revenue & Sales Performance
- New capacities at Gopalpur (TAN) and Dahej (acids) coming on stream will contribute to revenue growth starting Q3/Q4 FY27 and will achieve near-optimum utilization by FY28.
- Revenue uplift expected from capacity addition is calculable using shared average realizations and known production quantities.
- Growth will be driven by multiple levers: downstream expansion (DMSL), premiumization in crop nutrition and specialty fertilizers, and increasing specialty industrial chemicals.
- Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions.
- Integration benefits from the long-term LNG contract with Equinor and improved ammonia plant utilization will provide cost advantages and support margin stability.
- Management expects to progressively deleverage with improving earnings from new capacities, enabling sustainable growth trajectory.
- Overall strategy aims at transitioning from commodity to specialty and value-added products, enhancing revenue quality and stability.
Profitability & Margins
See what Deepak Fertilis. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Two major capex projects are in the final stage of commissioning and expected to be operational by end of Q3 FY27:
- - Gopalpur TAN plant (ammonium nitrate)
- - Dahej nitric acid plant
- These new capacities are expected to start contributing to revenue and EBITDA from Q3/Q4 FY27, with ramp-up possibly reaching around 80% utilization by Q4.
- The company has capitalized interest costs related to these projects, indicating ongoing investment.
- The new capacities will bolster integrated supply chain benefits, improve operating leverage, and drive the next growth phase.
- Management is also evaluating strategic options for the DMSL subsidiary, including IPO or demerger, to unlock value.
- The company is upgrading the explosives business facility post-acquisition, investing in safety and new plants, aiming to expand specialty product offerings in mining chemicals.
- Further growth beyond current capex will come from multiple levers, including downstream value-added products and portfolio premiumization.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Deepak Fertilis. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Deepak Fertilis. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.8K Cr, net profit ₹141 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Deepak Fertilisers & Petrochemicals Corp Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Solar Industries India Ltd (Q1 FY27)
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Chemicals Ltd (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF Ltd (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
Frequently Asked Questions
What were Deepak Fertilis. Q1 FY27 results?
New capacities at Gopalpur (TAN) and Dahej (acids) coming on stream will contribute to revenue growth starting Q3/Q4 FY27 and will achieve near-optimum utilization by FY28. The company is entering the next phase of growth with new capacities (Gopalpur TAN and Dahej nitric acid projects) commissioning in Q2 FY27, expected to contribute from Q3/Q4 FY27 onwards.
What is Deepak Fertilis. share price analysis?
Deepak Fertilis. currently shows a below-average growth signal. The stock trades at a P/E of 18.6 with a market cap of ₹18,294 Cr. Investors should review the full earnings analysis for detailed insights.
Is Deepak Fertilis. planning capital expenditure?
Two major capex projects are in the final stage of commissioning and expected to be operational by end of Q3 FY27: - Gopalpur TAN plant (ammonium nitrate) - Dahej nitric acid plant - These new capacities are expected to start contributing to revenue and EBITDA from Q3/Q4 FY27, with ramp-up possibly reaching around 80% utilization by Q4.
Keep Deepak Fertilis. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.